Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 4/20 | 0.53 |
| ▸ | GRM4 | Q14833 | 5/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | KDR | P35968 | 6/20 | 0.45 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.45 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.45 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.44 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL286902 | 0.93 | BACE1 (0.52) | BACE1GRM4HDAC6NPC1RAB9A | |
| SCHEMBL286974 | 0.88 | BACE1 (0.56) | BACE1 | |
| SCHEMBL287226 | 0.88 | BACE1 (0.41) | BACE1 | |
| SCHEMBL286810 | 0.87 | GRM4 (0.44) | BACE1GRM4 | |
| SCHEMBL287191 | 0.86 | BACE1 (0.54) | BACE1 | |
| SCHEMBL297469 | 0.72 | BACE1 (0.60) | BACE1GRM4HDAC6NPC1RAB9A | |
| SCHEMBL286878 | 0.71 | BACE1 (0.57) | BACE1 | |
| SCHEMBL7990375 | 0.69 | KDR (0.84) | GRM4HDAC6NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL10155180 | 0.69 | BACE1 (0.82) | BACE1 | |
| SCHEMBL287127 | 0.69 | BACE1 (0.78) | BACE1GRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2427437-A1 | DIHYDROPYRIMIDINONES FOR USE AS BACE2 INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2012-03-14 | — | — | EP | disclosed |